Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

Fukuhara, Noriko;Yamamoto, Go;Tsujimura, Hideki;Chou, Takaaki;Shibayama, Hirohiko;Yanai, Tomoko;Shibuya, Kazunori;Izutsu, Koji;
Leukemia & lymphoma 2020 Vol. 61 pp. 176-180
309
fukuhara2020retreatmentleukemia

Citation

ID: 105232
Ref Key: fukuhara2020retreatmentleukemia
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
105232
Unique Identifier:
10.1080/10428194.2019.1654100
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Saymatik Web3.0 Wallet